Logo image of CRZK.DE

CR ENERGY AG (CRZK.DE) Stock Fundamental Analysis

FRA:CRZK - Deutsche Boerse Ag - DE000A2GS625 - Common Stock - Currency: EUR

4.22  +0.07 (+1.69%)

Fundamental Rating

7

CRZK gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 63 industry peers in the Real Estate Management & Development industry. CRZK has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CRZK has a bad growth rate and is valued cheaply. CRZK also has an excellent dividend rating. These ratings could make CRZK a good candidate for value and dividend investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CRZK was profitable.
In the past year CRZK had a positive cash flow from operations.
CRZK had positive earnings in each of the past 5 years.
In multiple years CRZK reported negative operating cash flow during the last 5 years.
CRZK.DE Yearly Net Income VS EBIT VS OCF VS FCFCRZK.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M

1.2 Ratios

Looking at the Return On Assets, with a value of 16.28%, CRZK belongs to the top of the industry, outperforming 98.41% of the companies in the same industry.
With an excellent Return On Equity value of 16.72%, CRZK belongs to the best of the industry, outperforming 96.83% of the companies in the same industry.
With an excellent Return On Invested Capital value of 11.57%, CRZK belongs to the best of the industry, outperforming 98.41% of the companies in the same industry.
Industry RankSector Rank
ROA 16.28%
ROE 16.72%
ROIC 11.57%
ROA(3y)22.01%
ROA(5y)32.16%
ROE(3y)22.61%
ROE(5y)34.11%
ROIC(3y)N/A
ROIC(5y)N/A
CRZK.DE Yearly ROA, ROE, ROICCRZK.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

1.3 Margins

The Profit Margin of CRZK (95.83%) is better than 92.06% of its industry peers.
In the last couple of years the Profit Margin of CRZK has grown nicely.
CRZK has a better Operating Margin (96.71%) than 100.00% of its industry peers.
CRZK's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 96.71%
PM (TTM) 95.83%
GM N/A
OM growth 3YN/A
OM growth 5Y1.86%
PM growth 3YN/A
PM growth 5Y26.45%
GM growth 3YN/A
GM growth 5YN/A
CRZK.DE Yearly Profit, Operating, Gross MarginsCRZK.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1K 2K 3K

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CRZK is creating some value.
CRZK has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CRZK has been increased compared to 5 years ago.
The debt/assets ratio for CRZK is higher compared to a year ago.
CRZK.DE Yearly Shares OutstandingCRZK.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
CRZK.DE Yearly Total Debt VS Total AssetsCRZK.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

CRZK has an Altman-Z score of 7.53. This indicates that CRZK is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 7.53, CRZK belongs to the best of the industry, outperforming 98.41% of the companies in the same industry.
CRZK has a debt to FCF ratio of 0.29. This is a very positive value and a sign of high solvency as it would only need 0.29 years to pay back of all of its debts.
CRZK has a better Debt to FCF ratio (0.29) than 100.00% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that CRZK is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.02, CRZK belongs to the best of the industry, outperforming 90.48% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.29
Altman-Z 7.53
ROIC/WACC1.61
WACC7.18%
CRZK.DE Yearly LT Debt VS Equity VS FCFCRZK.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 195.92 indicates that CRZK has no problem at all paying its short term obligations.
CRZK has a better Current ratio (195.92) than 100.00% of its industry peers.
A Quick Ratio of 195.92 indicates that CRZK has no problem at all paying its short term obligations.
CRZK's Quick ratio of 195.92 is amongst the best of the industry. CRZK outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 195.92
Quick Ratio 195.92
CRZK.DE Yearly Current Assets VS Current LiabilitesCRZK.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

3

3. Growth

3.1 Past

CRZK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -85.78%.
CRZK shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.96% yearly.
CRZK shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -75.95%.
Measured over the past years, CRZK shows a very strong growth in Revenue. The Revenue has been growing by 21.14% on average per year.
EPS 1Y (TTM)-85.78%
EPS 3Y-40.31%
EPS 5Y6.96%
EPS Q2Q%-101.97%
Revenue 1Y (TTM)-75.95%
Revenue growth 3YN/A
Revenue growth 5Y21.14%
Sales Q2Q%-99.88%

3.2 Future

CRZK is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.79% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y215.5%
EPS Next 2Y77.9%
EPS Next 3Y53.78%
EPS Next 5Y-1.79%
Revenue Next Year-5.52%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CRZK.DE Yearly Revenue VS EstimatesCRZK.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CRZK.DE Yearly EPS VS EstimatesCRZK.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15 20

9

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 9.17, which indicates a very decent valuation of CRZK.
CRZK's Price/Earnings ratio is rather cheap when compared to the industry. CRZK is cheaper than 84.13% of the companies in the same industry.
CRZK is valuated cheaply when we compare the Price/Earnings ratio to 28.87, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 0.22, the valuation of CRZK can be described as very cheap.
Based on the Price/Forward Earnings ratio, CRZK is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
CRZK is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.38, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.17
Fwd PE 0.22
CRZK.DE Price Earnings VS Forward Price EarningsCRZK.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CRZK is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
87.30% of the companies in the same industry are more expensive than CRZK, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 4.23
EV/EBITDA 1.3
CRZK.DE Per share dataCRZK.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CRZK may justify a higher PE ratio.
CRZK's earnings are expected to grow with 53.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.04
PEG (5Y)1.32
EPS Next 2Y77.9%
EPS Next 3Y53.78%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 10.55%, CRZK is a good candidate for dividend investing.
CRZK's Dividend Yield is rather good when compared to the industry average which is at 7.08. CRZK pays more dividend than 92.06% of the companies in the same industry.
CRZK's Dividend Yield is rather good when compared to the S&P500 average which is at 2.46.
Industry RankSector Rank
Dividend Yield 10.55%

5.2 History

The dividend of CRZK decreases each year by -14.25%.
Dividend Growth(5Y)-14.25%
Div Incr Years0
Div Non Decr Years3
CRZK.DE Yearly Dividends per shareCRZK.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 0.5 1 1.5 2

5.3 Sustainability

7.16% of the earnings are spent on dividend by CRZK. This is a low number and sustainable payout ratio.
CRZK's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP7.16%
EPS Next 2Y77.9%
EPS Next 3Y53.78%
CRZK.DE Yearly Income VS Free CF VS DividendCRZK.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M
CRZK.DE Dividend Payout.CRZK.DE Dividend Payout, showing the Payout Ratio.CRZK.DE Dividend Payout.PayoutRetained Earnings

CR ENERGY AG

FRA:CRZK (4/28/2025, 7:00:00 PM)

4.22

+0.07 (+1.69%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)04-06 2025-04-06/amc
Earnings (Next)10-09 2025-10-09
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap99.25M
Analysts82.86
Price Target36.73 (770.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 10.55%
Yearly Dividend0.23
Dividend Growth(5Y)-14.25%
DP7.16%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 9.17
Fwd PE 0.22
P/S 1.45
P/FCF 4.23
P/OCF 4.22
P/B 0.25
P/tB 0.25
EV/EBITDA 1.3
EPS(TTM)0.46
EY10.9%
EPS(NY)19.34
Fwd EY458.23%
FCF(TTM)1
FCFY23.66%
OCF(TTM)1
OCFY23.67%
SpS2.92
BVpS16.73
TBVpS16.73
PEG (NY)0.04
PEG (5Y)1.32
Profitability
Industry RankSector Rank
ROA 16.28%
ROE 16.72%
ROCE 16.43%
ROIC 11.57%
ROICexc 12.15%
ROICexgc 12.16%
OM 96.71%
PM (TTM) 95.83%
GM N/A
FCFM 34.21%
ROA(3y)22.01%
ROA(5y)32.16%
ROE(3y)22.61%
ROE(5y)34.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-31.75%
ROICexc growth 3YN/A
ROICexc growth 5Y-22.78%
OM growth 3YN/A
OM growth 5Y1.86%
PM growth 3YN/A
PM growth 5Y26.45%
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.29
Debt/EBITDA 0.1
Cap/Depr 37.5%
Cap/Sales 0.02%
Interest Coverage 250
Cash Conversion 35.37%
Profit Quality 35.7%
Current Ratio 195.92
Quick Ratio 195.92
Altman-Z 7.53
F-Score3
WACC7.18%
ROIC/WACC1.61
Cap/Depr(3y)94.17%
Cap/Depr(5y)96.58%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)26.49%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-85.78%
EPS 3Y-40.31%
EPS 5Y6.96%
EPS Q2Q%-101.97%
EPS Next Y215.5%
EPS Next 2Y77.9%
EPS Next 3Y53.78%
EPS Next 5Y-1.79%
Revenue 1Y (TTM)-75.95%
Revenue growth 3YN/A
Revenue growth 5Y21.14%
Sales Q2Q%-99.88%
Revenue Next Year-5.52%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-12.95%
EBIT growth 3YN/A
EBIT growth 5Y23.39%
EBIT Next Year-6.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y42.55%
FCF growth 3YN/A
FCF growth 5Y50.91%
OCF growth 1Y42.49%
OCF growth 3YN/A
OCF growth 5Y50.73%